Purpose: The survival of patients with hepatocellular carcinoma (HCC) recurrence after
curative resection is usually poor. We sought to evaluate the safety and efficacy of adjuvant …

Background The aim of this study was to systematically evaluate and determine those
patients with hepatocellular carcinoma (HCC) that would benefit from the administration of …

Aim: The efficacy of transarterial chemoembolization (TACE) for inoperable hepatocellular
carcinoma (HCC) is positive, but for postoperative HCC, many studies have reported …

Purpose Hepatectomy is considered as the potentially curative treatment for hepatocellular
carcinoma (HCC) and used in some selected Stage IIIA HCC, which include multiple tumors …

Background: Although adjuvant transcatheter arterial chemoembolization (TACE) has been
used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC) …

AIM: To evaluate the effect of postoperative adjuvant transcatheter arterial
chemoembolization (TACE) on the prognosis of hepatocellular carcinoma (HCC) patients …

Objective: To evaluate the effect of preoperative transarterial chemoembolization (TACE) for
resectable large hepatocellular carcinoma (HCC). Summary Background Data: Resection of …

Background Microvascular invasion (MVI) has recently been reported to be an independent
prognostic factor in patients with hepatocellular carcinoma (HCC). This study compared the …

Background The optimal strategy for adjuvant therapy after curative resection for
hepatocellular carcinoma (HCC) patients with solitary tumor and microvascular invasion …

Background Patients with hepatocellular carcinoma (HCC) and microvascular invasion
(mVI) have shown dismal postoperative prognosis; however, whether adjuvant transarterial …